Collaboration to Tackle HIV in Fast-Track Cities
May 31, 2016.
ViiV Healthcare (a specialist HIV joint venture between GSK, Pfizer and now Shionogi) and the International Association of Providers of AIDS Care (IAPAC) have announced a global collaboration to support 16 cities around the world that are participating in Fast-Track Cities, a global partnership between IAPAC, the Joint UN Program on HIV/AIDS (UNAIDS), the UN Human Settlements Program (UN-Habitat), and the City of Paris.
The collaboration will focus on 16 cities where HIV is highly prevalent: Amsterdam, Atlanta, Bangkok, Brussels, Bucharest, Buenos Aires, Dar es Salaam, Denver, Durban, Geneva, Kingston, Miami, Nairobi, Paris, Rio de Janeiro, and San Francisco. It aims to
- Increase utilization of combination prevention: a mix of effective and proven HIV prevention interventions, including condom provision, and the immediate initiation of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP)
- Reduce to zero the negative impact of discrimination and stigma, including in healthcare settings
- Monitor and report progress through a standardized approach to data generation, analysis, and reporting that embraces local and global accountability and the use of "open data".
The Fast-Track Cities initiative aims to strengthen and leverage existing HIV programs and resources to accelerate locally coordinated, city-wide responses to end AIDS as a public health threat by 2030. To date, 65 cities have joined the initiative.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
